Literature DB >> 347364

Effects of diet and behavior therapy on social and motor behavior of retarded phenylketonuric adults: an experimental analysis.

D Marholin, R E Pohl, R M Stewart, P E Touchette, N M Townsend, E H Kolodny.   

Abstract

The effects of a low phenylalanine diet on six retarded phenylketonuric adults were assessed. An ABA individual-subject design was used in experiment I to assess the effects of a low phenylalanine diet on social and motor behavior. Following a baseline during which the subjects ingested a normal phenylalanine diet (phase A), a low phenylalanine diet (phase B) was administered in a double blind fashion. Finally, the baseline condition (phase A) was reinstated (normal diet). The low phenylalanine diet resulted in few significant behavioral changes for those subjects with which proper methodologic controls were employed. However, for two of six subjects motor behavior, including stereotypy and tremor, seem to have ameliorated. In experiment II, applied behavior analysis techniques, including differential reinforcement of other behavior and time out, were combined to radically reduce the frequency of stereotypy and self-abuse exhibited by one of the six subjects of experiment I.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 347364     DOI: 10.1203/00006450-197803000-00004

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  6 in total

1.  Improvements in behaviour and physical manifestations in previously untreated adults with phenylketonuria using a phenylalanine-restricted diet: a national survey.

Authors:  S Yannicelli; A Ryan
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

2.  Behavioural and emotional problems in early-treated adolescents with phenylketonuria in comparison with diabetic patients and healthy controls.

Authors:  J Weglage; M Grenzebach; M Pietsch; R Feldmann; R Linnenbank; J Denecke; H G Koch
Journal:  J Inherit Metab Dis       Date:  2000-07       Impact factor: 4.982

3.  Withdrawal of chronic chlorpromazine medication: an experimental analysis.

Authors:  D Marholin; P E Touchette; R M Stewart
Journal:  J Appl Behav Anal       Date:  1979

Review 4.  The complete European guidelines on phenylketonuria: diagnosis and treatment.

Authors:  A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2017-10-12       Impact factor: 4.123

Review 5.  Systematic Review and Meta-Analysis of Neuropsychiatric Symptoms and Executive Functioning in Adults With Phenylketonuria.

Authors:  Deborah A Bilder; J Kay Noel; Erin R Baker; William Irish; Yinpu Chen; Markus J Merilainen; Suyash Prasad; Barbara J Winslow
Journal:  Dev Neuropsychol       Date:  2016-11-02       Impact factor: 2.253

6.  Systematic Review of N-of-1 Studies in Rare Genetic Neurodevelopmental Disorders: The Power of 1.

Authors:  Annelieke R Müller; Marion M M G Brands; Peter M van de Ven; Kit C B Roes; Martina C Cornel; Clara D M van Karnebeek; Frits A Wijburg; Joost G Daams; Erik Boot; Agnies M van Eeghen
Journal:  Neurology       Date:  2021-01-27       Impact factor: 9.910

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.